Latest News

Listen: An uncertain Alzheimer’s idea, blockbuster fish oil, & a little self-indulgence

Is the latest Alzheimer’s drug for real? Is three a crowd in CAR-T? And what’s a Bionomy?

We discuss all that and more on the latest episode of “The Readout LOUD,” STAT’s biotech podcast. First, medicinal chemist Derek Lowe joins us to discuss China’s surprising decision to approve a new treatment for Alzheimer’s disease — and why the resulting hope quickly turned to skepticism among experts. Then, we preview an all-important FDA meeting about Amarin and it’s fish-oil-derived cardiovascular drug. Later, we talk about how Celgene might find itself on the outside looking in when it comes to CAR-T cancer therapy. Finally, in honor of STAT’s fourth birthday, executive editor Rick Berke joins us to discuss the publication’s origins and where it’s headed.

Read the rest…

Source link




Related posts

Keep Moving to Keep Brain Sharp in Old Age

Newsemia

Harnessing reliability for neuroscience research

Newsemia

Pharma Owners Accused of Lying About OxyContin

Newsemia

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy